Research ArticleDiagnostics

T2 Magnetic Resonance Enables Nanoparticle-Mediated Rapid Detection of Candidemia in Whole Blood

See allHide authors and affiliations

Science Translational Medicine  24 Apr 2013:
Vol. 5, Issue 182, pp. 182ra54
DOI: 10.1126/scitranslmed.3005377

You are currently viewing the editor's summary.

View Full Text

Log in to view the full text

Log in through your institution

Log in through your institution

Nanoparticle Clusters Rapidly Detect Candida

Time is not on the side of patients suspected of blood infection (sepsis). Patients with bloodstream infections of Candida species are often misdiagnosed. Or, the diagnosis comes too late. These two factors contribute to a high mortality rate of 40% from this fungus. To deliver a quick and accurate diagnosis for candidemia, Neely and colleagues designed an assay that combines nanotechnology and clinical imaging.

The authors developed a nano-inspired platform that detects DNA from five of the most common Candida species found in patient blood. Candida cells were first lysed mechanically, and then polymerase chain reaction primers and a polymerase-like enzyme were added to selectively amplify the released DNA. Nanoparticles with complementary “capture probes” could then bind to the amplified DNA. At that point, the free particles clustered together, allowing for detection with T2 magnetic resonance (T2MR). Neely et al. built a portable T2MR instrument for detecting the fungal DNA at the patient’s bedside. With this technology, they were able to detect down to three colony-forming units (CFU) of C. albicans and C. tropicalis per milliliter of blood; even lower limits of detection (1 to 2 CFU/ml) were observed for C. krusei, C. glabrata, and C. parapsilosis. Using whole-blood samples from 24 patients, the authors were able to correctly identify the 8 candidemic patients, without any false-positive readouts from blood samples that contained bacteria.

The combination of nanoparticles and clinical MR detection allowed for specific detection of Candida species in infected patients’ blood. The T2MR readouts were even more sensitive than blood culture, showing residual Candida cells in patients undergoing treatment with antifungal medication days after blood culture tests were negative. With such portability and sensitivity, this nanoparticle platform could be used in the clinic to diagnose blood infection earlier than standard culture, thus allowing for rapid treatment of septic patients, where time is of the essence.

View Full Text

Stay Connected to Science Translational Medicine